Compare CSGP & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSGP | ELAN |
|---|---|---|
| Founded | 1987 | 1954 |
| Country | United States | United States |
| Employees | N/A | 9900 |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 13.2B |
| IPO Year | 1998 | 2018 |
| Metric | CSGP | ELAN |
|---|---|---|
| Price | $30.82 | $26.77 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 16 |
| Target Price | ★ $35.85 | $31.00 |
| AVG Volume (30 Days) | ★ 6.0M | 5.3M |
| Earning Date | 10-27-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.32 | 0.26 |
| Revenue | $965,230,000.00 | ★ $4,715,000,000.00 |
| Revenue This Year | $15.94 | $10.10 |
| Revenue Next Year | $11.36 | $4.97 |
| P/E Ratio | ★ $94.11 | $102.13 |
| Revenue Growth | ★ 15.23 | 6.22 |
| 52 Week Low | $25.89 | $19.40 |
| 52 Week High | $70.57 | $27.98 |
| Indicator | CSGP | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 49.93 | 68.11 |
| Support Level | $26.83 | $21.98 |
| Resistance Level | $31.76 | $27.85 |
| Average True Range (ATR) | 1.53 | 0.92 |
| MACD | -0.18 | 0.33 |
| Stochastic Oscillator | 57.57 | 89.70 |
CoStar Group is a global provider of proprietary information, analytics, and online marketplaces serving both commercial and residential real estate. The firm operates through a diverse portfolio of brands, including CoStar Suite for commercial real estate research, LoopNet for commercial listings, Apartments.com for multifamily rentals, and Homes.com for residential brokerage. It primarily sells high-margin software-as-a-service subscriptions that provide institutional clients with forensic property data and premium advertising visibility. With operations across North America, Europe, and Asia-Pacific, CoStar maintains the industry's most comprehensive centralized real estate database, functioning as a critical information utility for brokers, lenders, and owners worldwide.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.